09:20 AM EDT, 03/12/2024 (MT Newswires) -- Hans Lennart Rudolf Wigzell, Director, on March 08, 2024, sold 15,000 shares in Sarepta Therapeutics ( SRPT ) for $1,848,795. Following the Form 4 filing with the SEC, Wigzell has control over a total of 22,840 shares of the company, with 22,840 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/873303/000095017024029536/xslF345X03/ownership.xml

Price: 123, Change: +1.42, Percent Change: +1.17